N/A
N=42
Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program
Chronic Heart Failure
Bottom Line
View on ClinicalTrials.gov: NCT02087670 ↗Enrolled (actual)
42
Serious AEs
0.0%
Results posted
Aug 2014
Primary outcome: Primary: Natriuretic Brain Pro-peptid — 312; 200 pg/ml
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- controlled, supervised exercise protocol (Other); exercise protocol no supervised (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Grupo Rehabilitacion en Salud
- Primary completion
- Jan 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Natriuretic Brain Pro-peptid |
312; 200 | — |
| SECONDARY Oxygen Consumption |
831; 919 | — |
Summary
Evaluate pro-BNP levels, oxygen consumption, functional class, and quality of life in patients with chronic heart failure after participating in an exercise program and compare them baseline and 2 months, with another group who underwent an educational program.
Eligibility Criteria
Inclusion Criteria
- Patients older than 18 years, diagnosed with heart failure (NYHA) II-IV for more than six months
Exclusion Criteria
- patients with NYHA functional class I, who had attended a cardiac rehabilitation program previously, patients with decompensated diabetes mellitus, hypertension difficult to control, ischemic heart disease in the last month, prior pulmonary embolism, chronic obstructive pulmonary disease, restrictive lung disease , aortic stenosis, new episode of atrial fibrillation and musculoskeletal diseases that limit the performance of physical activity
Data sourced from ClinicalTrials.gov (NCT02087670). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.